Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

The dynamic epigenome and its implications in toxicology.

Szyf M.

Toxicol Sci. 2007 Nov;100(1):7-23. Epub 2007 Aug 3. Review.

PMID:
17675334
2.

Maternal care, the epigenome and phenotypic differences in behavior.

Szyf M, Weaver I, Meaney M.

Reprod Toxicol. 2007 Jul;24(1):9-19. Epub 2007 May 10. Review.

PMID:
17561370
3.

The social environment and the epigenome.

Szyf M, McGowan P, Meaney MJ.

Environ Mol Mutagen. 2008 Jan;49(1):46-60. Review.

PMID:
18095330
4.

Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.

Sigalotti L, Fratta E, Coral S, Cortini E, Covre A, Nicolay HJ, Anzalone L, Pezzani L, Di Giacomo AM, Fonsatti E, Colizzi F, Altomonte M, Calabrò L, Maio M.

J Cell Physiol. 2007 Aug;212(2):330-44. Review.

PMID:
17458893
5.

A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.

Reamon-Buettner SM, Borlak J.

Reprod Toxicol. 2007 Jul;24(1):20-30. Epub 2007 May 22. Review.

PMID:
17596910
6.

Novel approaches on epigenetics.

Papait R, Monti E, Bonapace IM.

Curr Opin Drug Discov Devel. 2009 Mar;12(2):264-75. Review.

PMID:
19333872
7.
8.

Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.

Santini V, Gozzini A, Ferrari G.

Curr Drug Metab. 2007 May;8(4):383-93. Review.

PMID:
17504226
9.

Small molecule modulators in epigenetics: implications in gene expression and therapeutics.

Swaminathan V, Reddy BA, Ruthrotha Selvi B, Sukanya MS, Kundu TK.

Subcell Biochem. 2007;41:397-428. Review.

PMID:
17484138
10.

Environmental epigenomics: understanding the effects of parental care on the epigenome.

McGowan PO, Szyf M.

Essays Biochem. 2010 Sep 20;48(1):275-87. doi: 10.1042/bse0480275. Review.

PMID:
20822499
11.

Cancer susceptibility: epigenetic manifestation of environmental exposures.

Weidman JR, Dolinoy DC, Murphy SK, Jirtle RL.

Cancer J. 2007 Jan-Feb;13(1):9-16. Review.

PMID:
17464241
12.

Epigenetics in cancer: targeting chromatin modifications.

Ellis L, Atadja PW, Johnstone RW.

Mol Cancer Ther. 2009 Jun;8(6):1409-20. doi: 10.1158/1535-7163.MCT-08-0860. Epub 2009 Jun 9. Review.

13.

Histone acetylation in gene regulation.

Verdone L, Agricola E, Caserta M, Di Mauro E.

Brief Funct Genomic Proteomic. 2006 Sep;5(3):209-21. Epub 2006 Jul 28. Review.

PMID:
16877467
14.

The epigenetics of social adversity in early life: implications for mental health outcomes.

McGowan PO, Szyf M.

Neurobiol Dis. 2010 Jul;39(1):66-72. doi: 10.1016/j.nbd.2009.12.026. Epub 2010 Jan 4. Review.

PMID:
20053376
15.

Epigenetic screening in product safety assessment: are we there yet?

Rasoulpour RJ, LeBaron MJ, Ellis-Hutchings RG, Klapacz J, Gollapudi BB.

Toxicol Mech Methods. 2011 May;21(4):298-311. doi: 10.3109/15376516.2011.557883. Review.

PMID:
21495868
16.

Epigenetic mechanisms in glioblastoma multiforme.

Nagarajan RP, Costello JF.

Semin Cancer Biol. 2009 Jun;19(3):188-97. doi: 10.1016/j.semcancer.2009.02.005. Epub 2009 Feb 20. Review.

PMID:
19429483
17.

The cancer epigenome--components and functional correlates.

Ting AH, McGarvey KM, Baylin SB.

Genes Dev. 2006 Dec 1;20(23):3215-31. Review.

18.

The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.

Bronner C, Chataigneau T, Schini-Kerth VB, Landry Y.

Curr Med Chem. 2007;14(25):2629-41. Review.

PMID:
17979715
19.

Epigenetic tête-à-tête: the bilateral relationship between chromatin modifications and DNA methylation.

D'Alessio AC, Szyf M.

Biochem Cell Biol. 2006 Aug;84(4):463-76. Review.

PMID:
16936820
20.

Histone acetylation and chromatin signature in stem cell identity and cancer.

Shukla V, Vaissière T, Herceg Z.

Mutat Res. 2008 Jan 1;637(1-2):1-15. Epub 2007 Aug 1. Review.

PMID:
17850830

Supplemental Content

Support Center